Xanthus Life Sciences, Inc.
Records under this name other than patents Xanthus Life Sciences, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Xanthus Life Sciences, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,989,390 | Amonafide salts Formerly held Lapsed on the fee record Ended Jan 24, 2014 · From the USPTO record | Lapsed on the fee record | Ended Jan 24, 2014 | From the USPTO record |
| US 6,740,305 | Assessment of gastric emptying disorders Lapsed on the fee record Ended May 25, 2012 · From the USPTO record | Lapsed on the fee record | Ended May 25, 2012 | From the USPTO record |
| US 6,693,198 | Amonafide salts Formerly held Lapsed on the fee record Ended Feb 17, 2012 · From the USPTO record | Lapsed on the fee record | Ended Feb 17, 2012 | From the USPTO record |
| US 6,610,270 | In vivo determination of metabolic function for use in therapy management Lapsed on the fee record Ended Aug 26, 2011 · From the USPTO record | Lapsed on the fee record | Ended Aug 26, 2011 | From the USPTO record |
| US 6,284,219 | In vivo determination of metabolic function for use in therapy management Lapsed on the fee record Ended Sep 4, 2009 · From the USPTO record | Lapsed on the fee record | Ended Sep 4, 2009 | From the USPTO record |
| US 6,846,842 | Pyruvate Ester Composition and Method of Use for Resuscitation After Events of Ischemia and Reperfusion Lapsed on the fee record Ended Jan 25, 2009 · Medium confidence | Lapsed on the fee record | Ended Jan 25, 2009 | Medium confidence |
| US 5,095,027 | Method for treating reperfusion injury employing L-2-oxothiazolidine-4-carboxylic acid Term ended Term ended no later than Mar 10, 2012 · Low confidence | Term ended | Term ended no later than Mar 10, 2012 | Low confidence |
| US 5,183,821 | Method for treating leukemias using N-(2-dimethylaminoethyl)-3-amino-1,8-naphthalimide for treating leukemias and solid tumors Formerly held Term ended Term ended no later than Feb 2, 2013 · Low confidence | Term ended | Term ended no later than Feb 2, 2013 | Low confidence |
| US 5,208,249 | Method for stimulating intracellular synthesis of glutathione using esters of L-2-oxothiazolidine-4-carboxylate Term ended Term ended no later than May 4, 2013 · Low confidence | Term ended | Term ended no later than May 4, 2013 | Low confidence |
| US 5,306,724 | Method for preventing and treating atherosclerosis Term ended Term ended no later than Apr 26, 2014 · Low confidence | Term ended | Term ended no later than Apr 26, 2014 | Low confidence |